Literatur
-
1
Nicolaides K H, Spencer K, Avgidou K. et al .
Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Ultrasound Obstet Gynecol.
2005;
25
221-226
-
2
Perni S C, Predanic M, Kalish R B. et al .
Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials.
Am J Obstet Gynecol.
2006;
194
127-30
-
3
Falik-Zaccai T, Golan N, Cuckle H.
Prenatal diagnosis for chromosomal abnormality: time to change the Israeli Policy.
Harefuah.
2006;
145
916-922
-
4
Summers A M, Langlois S, Wyatt P. et al .
Society of Obstetricians and Gynae-cologists of Canada. Prenatal screening for fetal aneuploidy.
J Obstet Gynaecol Can.
2007;
29
146-179
-
5
Dingeon B, Lebrun C, Doche C.
Modernizing trisomy 21 screening in France.
Presse Med.
2007;
36
5-7
-
6
Leung T Y, Chan L W, Leung T N. et al .
First-trimester combined screening for trisomy 21 in a predominantly Chinese population.
Ultrasound Obstet Gynecol.
2007;
29
14-17
-
7
Kozlowski P, Knippel A J, Stressig R.
Comparing First Trimester Screening Performance: Routine Care Gynaecologists’ Practices vs. Prenatal Centre. Vergleich von Ergebnissen des Erst-Trimester-Screenings: Gynäkologische Praxen vs. Pränatalzentrum.
Ultraschall in Med.
2007;
eFirst
-
8 Nicolaides K H, Sebire N J, Snijders J M. The 11 - 14-week Scan. The Diagnosis of Fetal Abnormalities. New York, London; The Parthenon Publishing Group 1999
-
9
Hyett J A, Perdu M, Sharland G K. et al .
Using fetal nuchal translucency to screen for congenital cardial defects at 10 - 14 weeks of gestation: population based cohort study.
Br Med J.
1999;
318
81-85
-
10
Souka A P, Krampl E, Bakalis S. et al .
Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
Ultrasound Obstet Gynecol.
2001;
18
9-17
-
11 Merz E. Erstrimesterscreening (NT-Screening). Diedrich K, Felberbaum R, Polack S, Tauchert S Fortschritt ermöglichen - Grenzen erkennen. Kongressband, 55. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. 2004 2005: 150-155
-
12
Merz E, Meinel K, Bald R. et al .
DEGUM-Stufe III-Empfehlung zur „weiterführenden” sonographischen Untersuchung im Zeitraum 11 - 14 Schwangerschaftswochen.
Ultraschall in Med.
2004;
25
218-220
-
13
Cicero S, Curcio P, Papageorhiou A. et al .
Absence of nasal bone in fetuses with trisomy 21 at 11 - 14 weeks of gestation.
Lancet.
2001;
358
1665-1667
-
14
Merz E.
The Fetal Nasal Bone in the First Trimester - Precise Assessment using 3D Sonography (Das fetale Nasenbein im ersten Trimenon - gezielte Beurteilung mittels 3D-Sonographie).
Ultraschall in Med.
2005;
26
365-366
-
15
Kozlowski P, Knippel A J, Froehlich S. et al .
Additional performance of nasal bone in first trimester screening.
Ultraschall in Med.
2006;
27
336-339
Prof. Dr. E. Merz
Frauenklinik, Krankenhaus Nordwest
Steinbacher Hohl 2-26
60488 Frankfurt/Main
Phone: ++49/69/76 01/35 79
Fax: ++49/69/76 01/36 13
Email: merz.eberhard@khnw.de
